Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Nida Cao"'
Autor:
Fangqi Ma, Mingming Ren, Zhongqiu Li, Yujing Tang, Xiaoyu Sun, Yi Wang, Nida Cao, Xiaohong Zhu, Yan Xu, Rui Wang, Yumiao Shen, Ruohan Zhao, Zhaoyan Li, Milad Ashrafizadeh, Gautam Sethi, Furong Wang, Aiguang Zhao
Publikováno v:
Pharmacological Research, Vol 210, Iss , Pp 107499- (2024)
ARID1A deletion mutation contributes to improved treatment of several malignancies with immune checkpoint inhibitors (ICIs). However, its role in modulating of tumor immune microenvironment (TIME) of gastric cancer (GC) remains unclear. Here, we repo
Externí odkaz:
https://doaj.org/article/6edfe2f16e934a929e551f3d8ed57aab
Autor:
Qian Li, Minzhi Lv, Lihua Lv, Nida Cao, Aiguang Zhao, Jiayan Chen, Xi Tang, Rongkui Luo, Shan Yu, Yan Zhou, Yuehong Cui, Wei Guo, Tianshu Liu
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4110-4124 (2023)
Abstract Purpose This study aimed to evaluate the clinical relevance of exosomal HER2 (Exo HER2) level in assessing the tissue HER2 status and predicting the efficacy of trastuzumab treatment. Methods In this prospective study, patients with advanced
Externí odkaz:
https://doaj.org/article/d5f64d8b0c51479a84b8883a253d4f90
Autor:
Guangtao Zhang, Zhaoyan Li, Jiahuan Dong, Weili Zhou, Zhanxia Zhang, Zujun Que, Xiaohong Zhu, Yan Xu, Nida Cao, Aiguang Zhao
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Epithelial-to-mesenchymal transition (EMT) is a pivotal cellular phenomenon involved in tumour metastasis and progression. In gastric cancer (GC), EMT is the main reason for recurrence and metastasis in postoperative patients. Aca
Externí odkaz:
https://doaj.org/article/0c31992d839647958ba307a0f325e70f
Autor:
Zhaoyan Li, Guangtao Zhang, Nida Cao, Jingjuan Xu, Jiahuan Dong, Jia Li, Xiaohong Zhu, Yan Xu, Chen Han, Rui Wang, Xiang Xia, Gang Zhao, Xiangkun Huan, Jin Fan, Aiguang Zhao
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background Metastasis and/or recurrence can decrease the survival time of gastric cancer patients undergoing radical operation. Among them, those with stage IIIb and IIIc are especially at a high risk of metastasis and recurrence. The tradit
Externí odkaz:
https://doaj.org/article/147688ac8d804ceca38b42a35df55ff9
Autor:
Jia Li, Zhaoyan Li, Yajie Ding, Yan Xu, Xiaohong Zhu, Nida Cao, Chen Huang, Mengmeng Qin, Feng Liu, Aiguang Zhao
Publikováno v:
PeerJ, Vol 9, p e11146 (2021)
Background Gastric cancer (GC) is a heterogeneous disease that encompasses various molecular subtypes. The molecular mutation characteristics of circulating tumor DNA (ctDNA) in advanced gastric cancer (AGC), especially the clinical utility of TP53 m
Externí odkaz:
https://doaj.org/article/b8d77de396504281856658c132674052
Autor:
Qian Li, Minzhi Lv, Lihua Lv, Nida Cao, Aiguang Zhao, Jiayan Chen, Xi Tang, Rongkui Luo, Shan Yu, Yan Zhou, Yuehong Cui, Wei Guo, Tianshu Liu
Publikováno v:
Cancer Medicine. 12:4110-4124
This study aimed to evaluate the clinical relevance of exosomal HER2 (Exo HER2) level in assessing the tissue HER2 status and predicting the efficacy of trastuzumab treatment.In this prospective study, patients with advanced gastric cancer (AGC) from
Autor:
Thomas Friedemann, Edda Kark, Nida Cao, Matthias Klaßen, Gesa Meyer-Hamme, Johannes Henry Greten, Matthias Rostock, Elisabeth Buhlmann, Aiguang Zhao, Sven Schröder
Publikováno v:
Phytomedicine. 104:154294
Chemotherapy-induced peripheral neuropathy (CIPN) is recognized as the second commonest side effect after chemotherapy. Besides neurological deficits and pain, it is a potential reason for terminating chemotherapy. Effective curative treatments of ne
Autor:
Mengmeng Qin, Xiaohong Zhu, Jin Fan, Nida Cao, Xiang Xia, Jia Li, Zhaoyan Li, Gang Zhao, Yan Xu, Rui Wang, Guangtao Zhang, Xiangkun Huan, Chen Han, Feng Liu, Aiguang Zhao
BackgroundMetastasis and/or recurrence are the primary cause in decreasing the survival time of gastric cancer patients who experienced radical operation. Among whom, patients with stage IIIb and IIIc are especially in high risk of metastasis and rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8442a7f406a5bac6d0dc3d2f131b0a1
https://doi.org/10.21203/rs.3.rs-486842/v1
https://doi.org/10.21203/rs.3.rs-486842/v1
Autor:
Zhaoyan Li, Guangtao Zhang, Nida Cao, Jingjuan Xu, Jiahuan Dong, Jia Li, Xiaohong Zhu, Yan Xu, Chen Han, Rui Wang, Xiang Xia, Gang Zhao, Xiangkun Huan, Jin Fan, Aiguang Zhao
Publikováno v:
Trials
Trials, Vol 23, Iss 1, Pp 1-8 (2022)
Trials, Vol 23, Iss 1, Pp 1-8 (2022)
Background Metastasis and/or recurrence can decrease the survival time of gastric cancer patients undergoing radical operation. Among them, those with stage IIIb and IIIc are especially at a high risk of metastasis and recurrence. The traditional Chi
Autor:
Chen Huang, Mengmeng Qin, Feng Liu, Nida Cao, Zhaoyan Li, Yan Xu, Yajie Ding, Xiaohong Zhu, Ai-Guang Zhao, Jia Li
Publikováno v:
PeerJ
PeerJ, Vol 9, p e11146 (2021)
PeerJ, Vol 9, p e11146 (2021)
Background Gastric cancer (GC) is a heterogeneous disease that encompasses various molecular subtypes. The molecular mutation characteristics of circulating tumor DNA (ctDNA) in advanced gastric cancer (AGC), especially the clinical utility of TP53 m